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http://www.biomedcentral.com/1741-7015/12/157RESEARCH ARTICLE Open AccessThe association between dietary factors and
gestational hypertension and pre-eclampsia:
a systematic review and meta-analysis of
observational studies
Danielle AJM Schoenaker1*, Sabita S Soedamah-Muthu2 and Gita D Mishra1Abstract
Background: Dietary factors have been suggested to play a role in the prevention of hypertensive disorders of
pregnancy (HDP), including gestational hypertension and pre-eclampsia, but inconsistent findings have been
reported. A systematic review and meta-analyses were performed to synthesize evidence from observational studies
of reproductive-aged women on the association between dietary factors and HDP.
Methods: MEDLINE and EMBASE were searched to identify studies published until the end of May 2014. Studies
were included if they were observational studies of reproductive-age women and reported results on dietary factors
(energy, nutrients, foods or overall dietary patterns, alone or in combination with dietary supplements) and
gestational hypertension and/or pre-eclampsia. Studies were excluded if they reported on supplements not in
combination with dietary intake, or examined a biomarker of dietary intake. Random effects meta-analyses were
performed on calculated weighted mean differences (WMD) of dietary intake between cases and non-cases, and
effect estimates were pooled.
Results: In total, 23 cohort and 15 case–control studies were identified for systematic review, of which 16 could be
included in the meta-analyses. Based on meta-analyses of cohort studies, unadjusted energy intake was higher for
pre-eclampsia cases (WMD 46 kcal/day, 95% confidence interval (CI) −13.80 to 106.23; I2 = 23.9%, P = 0.26), although
this was not statistically significant. Unadjusted intakes of magnesium (WMD 8 mg/day, 95% CI −13.99 to −1.38;
I2 = 0.0%, P = 0.41) and calcium (WMD 44 mg/day, 95% CI −84.31 to −3.62, I2 = 51.1%, P = 0.03) were lower for the
HDP cases, compared with pregnant women without HDP. Higher calcium intake consistently showed lower odds
for HDP after adjustment for confounding factors (OR = 0.76, 95% CI 0.57 to 1.01, I2 = 0.0%, P = 0.79). A few studies
examining foods and dietary patterns suggested a beneficial effect of a diet rich in fruit and vegetables on
pre-eclampsia, although not all the results were statistically significant.
Conclusions: Based on a limited number of studies, higher total energy and lower magnesium and calcium intake
measured during pregnancy were identified as related to HDP. Further prospective studies are required to provide
an evidence base for development of preventive health strategies, particularly focusing on dietary factors during
pre-pregnancy and early pregnancy.
Please see related article: http://www.biomedcentral.com/1741-7015/12/176/abstract.
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Hypertension represents the most common complication of
pregnancy, affecting up to 15% of pregnancies worldwide
[1,2]. Hypertensive disorders of pregnancy (HDP) include
gestational hypertension, generally defined as new-onset
hypertension (≥140 mmHg systolic or ≥90 mmHg diastolic
blood pressure) arising after 20 weeks’ gestation, and pre-
eclampsia, defined as gestational hypertension accompanied
by proteinuria (excretion of ≥300 mg protein every 24 hours)
[1,3]. These disorders are a major cause of maternal
and perinatal morbidity and mortality [2], and result in
an increased future risk for cardiovascular disease [4,5]
and type 2 diabetes mellitus [4,6] for both mother and
offspring. These lifelong and inter-generational adverse
health consequences highlight the need for identifica-
tion of preventive strategies.
Although the etiology of gestational hypertension and
pre-eclampsia remains largely unclear, evidence suggests
that diet may play a role. HDP are characterized by
metabolic disturbances similar to those found in cardio-
vascular diseases and type 2 diabetes mellitus (T2DM)
including endothelial dysfunction, inflammation, oxida-
tive stress, insulin resistance and dyslipidemia [1,2]. Diet
is a well-known risk factor for cardiovascular disease
and T2DM [7,8]. Furthermore, serum nutrient levels
(such as elevated polyunsaturated fatty acids, and decreased
vitamins C and E, zinc, and iron) have been associated with
increased inflammation, oxidative stress, and dyslipidemia
[9,10]. Nutrient status has also been directly linked with
increased risk of pre-eclampsia, including increased serum
triglyceride and fatty acids, and reduced levels of serum
calcium, vitamin D, magnesium, and zinc [9]. Intervention
trials have examined the effect of single nutrient supple-
mentation in pregnant women on HDP risk, and recently
several systematic reviews and meta-analyses have syn-
thesized the results [11-15]. To date, however, the findings
do not support nutrient supplementation to reduce the
risk of HDP, with the exception of calcium supplementa-
tion [16]. Calcium supplementation during pregnancy is
recommended for prevention of pre-eclampsia in women
with low dietary calcium intake and for those at high risk
(for example, women with diabetes, renal disease, or auto-
immune disease) [17,18]. Evidence from observational
studies on the association between maternal nutrient in-
take and pre-eclampsia is inconsistent based on findings
from two narrative reviews [9,10]. To our knowledge, re-
views so far have summarized evidence on nutrient intake
in relation to pre-eclampsia, but findings on the associ-
ation between a wide range of maternal dietary factors
(nutrients, foods, overall diet) and both gestational hyper-
tension and pre-eclampsia from observational studies have
not been systematically reviewed.
This study aimed to systematically review all evidence
from observational studies in reproductive-age women onthe associations between dietary factors including energy,
nutrients, foods, and overall diet, alone or in combination




This review was carried out in accordance with the
Meta-analysis Of Observational Studies in Epidemiology
(MOOSE) guidelines [19]. A systematic search was per-
formed using MEDLINE and EMBASE to identify rele-
vant studies published from 1948 (MEDLINE) or 1966
(EMBASE) until the end of May 2014, using the search
queries shown in Additional file 1: Table S1. The search
was restricted to articles published in English and stud-
ies in human populations. Bibliographies of relevant arti-
cles and reviews were manually screened for additional
potentially relevant studies.
Criteria for inclusion in this systematic review were:
observational studies (including case–control and cross-
sectional, retrospective, and prospective cohort studies) of
women of reproductive age reporting results (in tables or
text) on the association between dietary factor(s) (exposure)
and gestational hypertension and/or pre-eclampsia
(outcome). Dietary factors included intake of energy,
nutrients, or foods, or overall dietary patterns, alone or
in combination with dietary supplements. Studies were
excluded if they reported on dietary supplements not
in combination with dietary intake, or examined a bio-
marker of dietary intake.
Relevance from title and abstract was assessed based
on these inclusion and exclusion criteria. If studies were
considered potentially relevant, the full-text article was
read. Two investigators (GDM and DAJMS) independently
reviewed full-text articles based on inclusion criteria. Any
disagreement was resolved by discussion.
Data extraction
Studies identified were case–control and cohort studies,
for which the following data were extracted: country,
population characteristics, age, sample size, dietary ex-
posure, dietary assessment method, validation and tim-
ing of dietary assessment, outcome, diagnostic criteria,
exclusion criteria, and confounders used in analysis.
For each individual dietary exposure, unadjusted and
adjusted dietary intake data for cases and non-cases as
well as effect estimates for the association between
dietary factors and gestational hypertension and/or
pre-eclampsia were extracted. If information on study
characteristics was missing, definitions were unclear,
or insufficient data were reported and could not be calcu-
lated (for example, missing standard deviation (SD) or con-
fidence interval (CI), dietary intake, or number of cases),
the authors were contacted for clarification or to request
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responded, of whom five were able provide additional infor-
mation on study characteristics or results.
Quality assessment
Two reviewers (GDM and DAJMS) independently assessed
the risk of bias using the Newcastle-Ottawa Scale (NOS)
for studies included in the systematic review [32]. Selection,
comparability, and outcome assessment were rated for
case–control and cohort studies separately. The rating-
system scores studies from 0 (highest degree of bias) to
9 (lowest degree of bias).
Meta-analysis
Extracted results were pooled in the meta-analyses when
at least two studies reported uniform units of dietary in-
take and associated effect estimates for HDP. Results
were presented using forest plots, separately for case–
control and cohort studies, for each dietary exposure
and each outcome (that is, gestational hypertension,
pre-eclampsia, and gestational hypertension and/or
pre-eclampsia). Dietary intake data were converted
into uniform units when inconsistently reported across
studies (kcal/day for total energy intake; mg/day for cal-
cium, vitamin C, and sodium; g/day for n-3 fatty acids
and mcg/day for vitamin D).
Using the available data, two meta-analyses were per-
formed. 1) For case–control and cohort studies report-
ing unadjusted mean dietary intake with SD or standard
error (SE) for cases and non-cases, the study-specific
weighted mean differences (WMD) with 95% CIs were
pooled, 2) For case–control and cohort studies report-
ing adjusted effect estimates (odds ratio (OR) or relative
risk (RR)) and corresponding 95% CI for a unit increase
in dietary intake or comparing the highest and lowest
categories of intake), these estimates were pooled to
obtain summary estimates for the associations be-
tween dietary factors and gestational hypertension
and/or pre-eclampsia. ORs and RRs were combined
into one meta-analysis if the incidence of the outcome
was ≤10% or the effect estimate was ≥0.5 or ≤2.5 [33].
Random effects models were used, and between-study
heterogeneity was assessed using the χ2 (Cochrane Q)
and I2 statistics [34]. In cases where one large study
dominated the result of a meta-analysis, this study was
excluded in additional analyses to explore how this al-
tered the pooled result. Exploring heterogeneity with
subgroup analysis or meta-regression was not possible
because of the limited number of studies. Publication
bias was assessed via a funnel plot for meta-analyses
including at least five study results. Statistical analyses
were conducted using Stata software (v13.0 (Stata
Corp., College Station, Texas). P < 0.05 was considered
statistically significant.Results
The systematic literature search identified 1,833 unique
articles. After screening of titles and abstracts, 86 studies
were considered relevant. The full text of these articles
was reviewed, and 38 met the inclusion criteria (Figure 1).
Of these, 17 studies reported results that could not be
pooled in meta-analyses, and were included in the system-
atic review only, while 21 studies reported data that could
be included in meta-analyses for different dietary factors.
Four studies [20,26,35,36] reporting on the association
between nutrient intake and both mild and severe pre-
eclampsia were included as four separate results in meta-
analyses. Another study [22] reported on dietary intake at
11–15, 26, and 34–37 weeks’ gestation. As diet assessed
prior to diagnosis would best predict development of the
disorder, only results on the association between diet
assessed at 11–15 weeks’ gestation and development of
pre-eclampsia were included in the review for this study
[22]. When multiple studies on the same study population
reported results for similar nutrients [20,24,37], the study
with the largest number of women was included [20].
Study characteristics
Study characteristics of the 38 included studies are
presented in Table 1. Women were all recruited dur-
ing pregnancy, and had a mean age between 23 and
29 years. Maternal age was comparable between cases
and non-cases even in non-matched case–control studies
(see Additional file 1: Table S2). In studies comparing
characteristics of cases and non-cases, body mass index
(BMI) and the proportion of nulliparous women were
consistently higher, and gestational age at delivery and in-
fant birth weight were consistently lower, for HDP cases
compared with non-cases (see Additional file 1: Table S2).
Number of pregnant women ranged from 92 to 928 in
case–control studies and from 65 to 63,226 in cohort stud-
ies. The prevalence ranged from 1.7 to 17.3% for gestational
hypertension, and from 1.3 to 7.6% for pre-eclampsia. Diet
was assessed mostly using food frequency questionnaires
(FFQs) (in 21 of 38 studies) that consisted of at least 120
food items and were validated in 16 studies. Outcome
measures were collected from medical records or linkage
with patient registries. In general, diagnostic criteria
were consistent across studies: gestational hypertension was
defined as new-onset hypertension (>140/90 mmHg) after
20 weeks’ gestation, and pre-eclampsia as gestational hyper-
tension accompanied by proteinuria (≥300 mg/24 hours)
(see Additional file 1: Table S3).
Quality assessment
Quality assessment ratings and scores are shown in
Additional file 1: Table S4. Total scores ranged from 3
to 8 for case–control studies and from 4 to 9 for cohort
studies, out of a maximum score of 9. Case definition
Figure 1 Flow diagram for selection of studies included in systematic review and meta-analyses on the association between dietary
factors and gestational hypertension and/or pre-eclampsia. Articles reporting on both gestational hypertension and pre-eclampsia were
included as two separate studies, and the number of studies suitable for pooling of results varied for the different dietary factors. (a) No desirable
outcome, for example, combined pre-eclampsia with disorders other than gestational hypertension or examined oxidative stress or blood
pressure in pregnancy; (b) No desirable exposure, that is, not reported on dietary intake as exposure.
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using hospital records in the majority of studies. In
addition, most cohort studies used dietary recall or a vali-
dated FFQ to assess dietary intake. Main concerns included
1) comparability of cases and non-cases on basis of design
or analysis (the majority of case–control studies and half of
the cohort studies did not match or adjust for important
confounding factors including maternal age, hypertension
prior to pregnancy, and parity); 2) exposure ascertainment
in case–control studies (most studies used non-validated
general questionnaires to assess dietary intake); and 3)
representativeness of the study samples (no information
on non-response rates in case–control studies, and se-
lection bias or insufficient information on derivation of
the sample in most cohort studies).Associations between nutrient intake and hypertensive
disorders of pregnancy
Results on differences in nutrient intake between HDP
cases and non-cases are shown in Additional file 2, and
associations between nutrient intake and HDP adjusted for
confounding factors in Additional file 3. Results for most
nutrients were sparse, inconsistent, or not statistically or
clinically significant (Additional files 2 and 3, meta-analyses
results not shown), with the exception of total energy,
magnesium, and calcium intake which are described in
more detail below.
Total energy intake
Five case–control studies [21,28,52,55,56] and ten co-
hort studies [20,22,24,37,40,42-44,49,50] reported on the
Table 1 Characteristics of studies included in the systematic review
Diet assessment
Reference Country N Cases, n (%) Population characteristics Age, yearsa Method Period Course Outcome
Cohort studies
Brantsæter
et al., 2011 [20]






recruited through a nationwide
postal invitation in connection with
their first routine ultrasonography
examination between 2002 and 2008




et al., 2012 [22]
Iran 584 23 (3.9) Pregnant women referred to 18
health centers and 12 private offices
in Isfahan between 2009 and 2010





11 to 15, 26, and







Norway 23,423 1,267 (5.4) Nulliparous pregnant women
recruited through a nationwide
postal invitation in connection with
their first routine ultrasonography











et al., 2009 [26]
Denmark 57,346 All subtypes:
1,487 (2.6) Severe
PE: 337 (0.6)
Pregnant women recruited when
first visiting their general practitioner
because of pregnancy between 1996
and 2002





Qiu et al., 2008
[29]
USA 1,538 64 (4.2) Pregnant women attending prenatal
care clinics affiliated with Swedish
Medical Center and Tacoma General
Hospital in Seattle and Tacoma,
Washington between 1996 and 2002
Mean ± SE:
32.2 ± 0.1
122-item FFQb First trimester Diet only PE
Triche et al.,
2008 [30]
USA 1,681 63 (3.7) Pregnant women recruited between
1996 and 2000 from 56 obstetric
practices and 15 clinics associated














USA 2,508 PE: 60 (2.4)
GH: 161 (6.4)
Pregnant women recruited at their
first prenatal visit between 1988














Brazil 1,052 Mild PE: 52 (4.9);
severe PE: 16
(1.5); GH: 36 (3.4)
Women who gave birth at Hospital
de Clínicas de Porto Alegre
Mean sge: GH




Dietary interview 1 day after delivery
(retrospective,
during pregnancy)




Norway 32,933 1,703 (5.2) Nulliparous pregnant women
recruited through a nationwide
postal invitation in connection with
their first routine ultrasonography
examination between 2002 and 2008
51% of women;
age range: 25 to 29




















Table 1 Characteristics of studies included in the systematic review (Continued)
Brantsæter
et al., 2009 [38]
Norway 23,423 1267 (5.4) Nulliparous pregnant women
recruited through a nationwide
postal invitation in connection with
their first routine ultrasonography
examination between 2002 and 2008
58% of women;
age range: 20 to 29





Denmark 63,226 2,206 (3.49) Pregnant women recruited when
first visiting their general practitioner
because of pregnancy between 1998
and 2003











classes, delivering between 1994
and 1996 at Aker Hospital in Oslo
Cases 29.2 ± 4.9;
non-cases 29.9 ± 4.5






et al., 2008 [41]
Congo 238 PE: 7 (2.9) GH:
4 (1.7)
Pregnant women admitted to the
Evangelical Hospital of Kimpese,
located in a rural area, between
2002 and 2003
Cases: 25.5 ± 7.2;








USA 4,314 PE : 326 (7.6)
GH: 747 (17.3)
Nulliparous pregnant women
enrolled in a randomized clinical trial
seeking prenatal care at university
medical centers and affiliated













USA 1,718 PE: 59 (3)
GH: 119 (7)
Pregnant women recruited at eight
offices of Harvard Vanguard Medical
Associates, a large multispecialty
urban/suburban group practice
in eastern Massachusetts, at first
prenatal visit between 1999 and 2002
~90% of women
age range: 20 to 40







Iceland 488 PE: 19 (3.9) GH:
30 (6.1)
Randomly selected pregnant
women, attending a routine first
visit at the Center of Prenatal Care
in Reykjavik from 1999 to 2001
GH cases 29 ± 6;
PE cases; 26 ± 4;
non-cases: 28 ± 5








Spain 82 6 (7.3) Pregnant women who were to
deliver at the Cuenca INSALUD
Hospital in Cuenca city area
between 1990-1991
Non-cases: 27.0 ± 3.9;
cases; 26.2 ± 3.4
5-day dietary
record





et al., 1995 [46]




Pregnant women who are members
of a prepaid medical insurance plan,
residing in the Oakland area of
California and who delivered











et al., 2009 [47]
USA 1,777 60 (3.4) Pregnant women recruited at eight
offices of Harvard Vanguard Medical
Associates, a large multispecialty
urban/suburban group practice in
eastern Massachusetts, at first
prenatal visit between 1999 and 2002
64% of women
range: 25 to 35
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Rumbold
et al., 2005 [48]
Australia 229 38 (12) GH or
PE, 20 (7) GH,
17 (5) PE
Women attending the antenatal
clinic of the Women’s and Children’s
Hospital for routine antenatal care in
Adelaide between April and July 2001
Cases: 28 ± 5 cases;
non-cases: 28 ± 5







Denmark 965 13 (1.3) Women recruited when attending
one of two antenatal clinics in
Aarhus between 1988 and 1989
Median (range):
28.7 (18 to 45)








USA 65 13 (20) Nulliparous pregnant women
recruited at the time of their first




cases: 25.3 ± 0.72






et al., 2011 [51]
Netherlands 3,187 PE: 58 (1.8) GH:
165 (5.2)
Pregnant women living in Rotterdam
delivering between 2002 and 2006
31.6 ± 4.0 293-item FFQb Early pregnancy
(median 13.5 wks,
IQR 3.4)






USA 511 172 cases, 339
controls
Women delivering at Swedish
Medical Center and Tacoma General
Hospital in Washington between
1998 and 2001. Controls were
normotensive women, delivering
on the same day as a case, matched
for parity and maternal age
Mean ± SEM: cases:
29.9 ± 0.5; controls:
30.6 ± 0.3








Turkey 247 92 cases,
155 controls
Pregnant women from Konya and
neighboring cities hospitalized with
pre-eclampsia at a clinic between
2004 and 2005. Controls were
healthy pregnant women visiting
the same institute for routine control





During pregnancy Diet only PE
Kesmodel
et al., 1997 [25]





study of women who delivered at
Aarhus University hospital between
1989 and 1991. Controls were evenly
distributed over and covering all
months of the period corresponding










Canada 928 PE: 172 (505
controls) GH: 251
(505 controls)
Pregnant women who delivered in
Quebec City or Montreal between
1984 and 1986. Controls were
women who delivered immediately
after the case in the same hospital
and had not more than one
elevated blood pressure reading
after 20 weeks of pregnancy
PE cases: 26.0 ± 4.8;
GH cases: 26.2 ± 4.3;

























Table 1 Characteristics of studies included in the systematic review (Continued)
Paknahad et al.,
2008 [28]
Iran 92 46 cases, 46
controls
Pregnant women attending Al-Zahra
and Shaheed Beheshti hospitals in
Isfahan. Controls were normotensive
pregnant women matched for age
and parity
Mean ± SE: cases:





33.7 ± 2.7 weeks’
gestation
Diet only PE or GH
Wei et al.,
2009 [36]





recruited within 48 hours after
delivery in four hospitals in Quebec.
Controls were normotensive
pregnant women delivering
during the same period as the case
Cases: 29.0 ± 5.2; controls:
29.1 ± 5.3





Netherlands 116 29 cases, 87
controls
Nested case–control study of
pregnant women recruited at
hospitals in the Maastricht region.
Cases were matched for parity
and hospital with controls with an
uncomplicated pregnancy who
delivered around the same time
Mean ± SEM:
controls: 28.5 ± 0.35;








Zimbabwe 374 180 cases,
194 controls
Pregnant women delivering at one
of nine clinics from the Harare
Maternity Hospital located in suburbs
of Harare city, between 1995 and
1996. Most patients were from poor
urban areas or migrated between
rural and urban areas. The first
healthy women admitted after
each case was used as a control
Cases: 25.6 ± 6.4;













Netherlands NR 163 cases Pregnant women selected from a
computer database and patient
charts in two hospitals between
1991 and 1996. Controls were
matched for age and delivery date
Median ± SD: cases:











Iran 263 113 cases,
150 controls
Pregnant women referred to Shahid
Akbarabadi Hospital between
January and May 2011. Controls
were pregnant women with normal
blood pressure referred to this
hospital for prenatal care,
matched for gestational age
Cases: 28.73 ± 6.04;
controls:
25.36 ± 4.84








Colombia 402 201 cases,
201 controls
Pregnant women recruited from six
Colombian cities between 2006 and
2009. Healthy pregnant controls
were matched for age and selected
from the same city of residence and
the same hospital of delivery as
the case
Cases: 26.45 ± 7.22;
controls: 26.71 ± 7.21





















Table 1 Characteristics of studies included in the systematic review (Continued)
Richards et al.,
2014 [57]
South Africa 192 96 cases,
96 controls
Women who delivered at the
Maternity Centre at Groote Schuur
Hospital and Mowbray Maternity
Hospital in Cape Town between
January and November 2010.
Healthy pregnant women who
delivered a live infant were matched
with cases by ethnicity, gravidity,
age, and gestational age at delivery
Cases: 24 ± 4.3;
controls: 24 ± 4.4
Questionnaire After delivery Diet only PE
Schiff et al.,
1996 [58]
USA 138 48 cases,
90 controls
Pregnant women admitted to the
EH Crump Women’s Hospital in
Memphis, Tennessee between
January 1994 and April 1995. Normal
outpatients with no evidence of
hypertension or proteinuria either
at recruitment or delivery in the
third trimester served as controls
Cases: 21.5 ± 5.4;
controls: 20.1 ± 4.4
>100-item
questionnaire






Iran 140 40 cases,
100 controls
Nulliparous pregnant women
recruited within 48 hours after
delivery in two hospitals in Tehran.
Controls were normotensive
pregnant women delivering
during the same time as the case
Cases: 28 ± 4.1;
controls: 27 ± 5





USA 368 109 cases,
259 controls
Women delivering at Swedish
Medical Center and Tacoma General
Hospital in Washington between
1998 and 2000. Controls were
normotensive women, delivering
on the same day of a case
Mean ± SEM: :
cases: 31.1 ± 0.6;
controls: 29.9 ± 4.5






FFQ, food frequency questionnaire; GH, gestational hypertension; NR, not reported; PE, pre-eclampsia; SD, standard deviation; SE, standard error; SEM, standard error of the mean.
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women with and without HDP (Additional file 2). Of
these, four case–control studies [28,52,55,56] and seven
cohort studies [20,22,40,42-44,50] were included in the
meta-analysis (Figure 2a and b, respectively). Results from
case–control studies were inconsistent, and did not show
an association between energy intake and HDP. Findings
from cohort studies indicated that pre-eclampsia cases re-
ported an energy intake of 46 kcal/day higher than women
without pre-eclampsia (95% CI −13.80 to 106.23; I2 =
23.9%, P = 0.26), although this was not statistically signifi-
cant. As the result for pre-eclampsia was dominated
(weight 69%) by findings from a large prospective cohort,
the Norwegian Mother and Child Cohort Study (MoBa)
[20], we additionally present the forest plot excluding this
study (see Additional file 1: Figure S1). With this exclusion,
the difference in total energy intake between pre-
eclampsia cases and non-cases became slightly larger and
statistically significant (87 kcal/day, 95% CI 5.99 to 168.11;
I2 = 0.0%, P = 0.45). Exclusion of the MoBa study did not
alter the overall non-significant result for HDP.
Only two studies reported multivariate results [40,55]
(Additional file 3; see Additional file 1: Table S5), that could
not be pooled because of different units of exposure. Results
from a Norwegian prospective cohort study [40] showed
higher odds for developing pre-eclampsia with higher early
second trimester energy intake (OR= 3.7, 95% CI 1.5 to 8.9,
highest versus lowest quartile). Kazemian et al. [55] re-
ported a positive association between higher energy in-
take and gestational hypertension in a case–control
study (OR = 1.33, 95% CI 1.17 to 1.52, per 200 kcal).
Magnesium
Two case–control studies [21,55] and four cohort studies
[22,42,43,49] reported on unadjusted magnesium intake in
women with and without HDP (Additional file 2), of
which three cohort studies [22,42,43] could be included
in the meta-analysis (Figure 3). Pooled results revealed
statistically significantly lower mean magnesium intake of
8 mg/day for women with HDP (95% CI −13.99 to −1.38;
I2 = 0.0%, P = 0.41).
Five studies [21,42,43,49,55] reported multivariate re-
sults for the association between magnesium intake and
HDP (Additional file 3; see Additional file 1: Table S5).
Estimates could not be pooled in meta-analysis because of
different units of exposure. Studies consistently trended
towards an inverse association between magnesium intake
and gestational hypertension [42,43,55] and pre-eclampsia
[21,42,43,49], although this was not statistically significant
(Additional file 3).
Calcium
Of seven case–control studies [21,25,27,28,35,55,56]
and six cohort studies [20,22,42,43,45,50] reporting onunadjusted calcium intake in HDP cases and non-
cases, three case–control studies [28,55,56] and seven
cohort studies [20,22,35,42,43,45,50] could be included
in the meta-analysis (Figure 4a and b, respectively).
Results from case–control studies consistently showed
lower reported calcium intake for HDP cases compared
with non-cases, but the pooled result was not statistically
significant (WMD = −39.89, 95% CI −109.52 to 29.75;
I2 36.6%; P = 0.21). Results from cohort studies showed
borderline significantly lower reported mean calcium intake
of 56 mg/day (95% CI −120.69 to 8.06) for pre-eclampsia
cases compared with non-cases, with moderate between-
study heterogeneity (I2 = 61.2%, P = 0.02). An overall mean
difference of 44 mg/day was found for women with HDP
(95% CI −84.31 to −3.62) with significant between-study
heterogeneity (I2 = 51.1%, P = 0.03).
Four case–control studies [21,25,27,55] and two cohort
studies [42,43] reported adjusted estimates for the associ-
ation between calcium intake and HDP (Additional file 3;
see Additional file 1: Table S5), of which three case–
control studies [21,25,27] could be included in the
meta-analysis (Figure 5). Calcium intake in the high-
est (>1600 mg/day approximately) compared with the
lowest (<1000 mg/day approximately) quintile consis-
tently showed lower odds for gestational hypertension
(OR = 0.63, 95% CI 0.41 to 0.97; I2 = 0.0%, P = 0.53) and
overall HDP (OR = 0.76, 95% CI 0.57 to 1.01; I2 = 0.0%,
P = 0.79).
Interpretation of the funnel plots for the association
between energy, magnesium and calcium and HDP showed
no suggestion of publication bias (P-values for Egger's test
for small-study effects all >0.05, data not shown).Associations between food groups/dietary patterns and
hypertensive disorders of pregnancy
Results for unadjusted and adjusted associations between
food groups and overall dietary patterns and HDP suggested
beneficial effects of fruit and vegetable consumption
(Additional file 4). These studies could not be pooled
in a meta-analysis because of differences in the foods
or patterns examined or different units of exposure.Fruit and vegetables
Six case–control [21,23,53,56,57,60] and four cohort
studies [26,37,40,41] examined the association between
fruit and/or vegetable consumption and pre-eclampsia
(Additional file 4). Two case–control studies (based
on one study population) [21,60] and two cohort stud-
ies [26,37], all adjusting for confounding factors (see
Additional file 1: Table S5), consistently suggested a bene-
ficial effect of higher fruit and/or vegetable consumption
on pre-eclampsia, although they were not all statisti-
cally significant.
Figure 2 (See legend on next page.)
Schoenaker et al. BMC Medicine 2014, 12:157 Page 11 of 18
http://www.biomedcentral.com/1741-7015/12/157
(See figure on previous page.)
Figure 2 Difference in unadjusted total energy intake (kcal/day) between cases (gestational hypertension, pre-eclampsia and
gestational hypertension or pre-eclampsia) and non-cases (reference) reported in case–control studies and cohort studies. For each
study, the center of each square indicates the weighted mean difference (WMD), and the horizontal line indicates the 95% confidence interval;
the area of the square is proportional to the weight that the individual study contributes to the overall pooled mean difference; and the
diamonds are pooled mean differences (for each outcome and overall). (a) Case–control studies. Meta-analysis of 4 studies from 4 articles with
data from 873 pregnant women, including 113 gestational hypertension, 230 pre-eclampsia, and 46 gestational hypertension or pre-eclampsia
cases. (b) Cohort studies. Meta-analysis of 10 studies from 7 articles with data from 43,701 pregnant women, including 896 gestational
hypertension, 2,267 pre-eclampsia, and 13 gestational hypertension or pre-eclampsia cases.
Schoenaker et al. BMC Medicine 2014, 12:157 Page 12 of 18
http://www.biomedcentral.com/1741-7015/12/157Dietary patterns
Only three studies reported on the associations between
overall dietary patterns and HDP [38,47,51]. In the MoBa
study (23,423 women, including 1,267 pre-eclampsia cases)
[38] inverse associations were found with development of
pre-eclampsia in women with high scores on a dietary pat-
tern (identified by factor analysis) characterized by vegeta-
bles, plant foods, and vegetable oils (third versus first tertile
OR = 0.72, 95% CI 0.62 to 0.85), and higher odds of pre-
eclampsia were found in women with a dietary pattern
characterized by processed meat, salty snacks, and
sweet drinks (OR = 1.21, 95% CI 1.03 to 1.42). Studies by
Timmermans et al. [51] (3,187 women, including 165Figure 3 Difference in unadjusted magnesium intake (mg/day) betwe
non-cases (reference) reported in cohort studies. For each study, the ce
and the horizontal line indicates the 95% confidence interval; the area of th
contributes to the overall pooled mean difference; and the diamonds are p
of 5 studies from 3 articles with data from 6,616 pregnant women, includingestational hypertension and 58 pre-eclampsia cases)
and Rifas-Shiman et al. [47] (1,777 women, including
60 pre-eclampsia cases) were smaller and less conclu-
sive. In the Generation R study [51], an association was
found between low adherence to a Mediterranean-style
dietary pattern and high adherence to a traditional dietary
pattern, identified by factor analysis and higher blood
pressure during pregnancy, but these patterns were not
associated with gestational hypertension or pre-eclampsia
outcomes. In the US cohort study Project Viva [47], diet
quality, as measured by the Alternate Healthy Eating Index
slightly modified for pregnancy (AHEI-P), was not as-
sociated with pre-eclampsia (OR = 0.96, 95% CI 0.84 toen cases (gestational hypertension and pre-eclampsia) and
nter of each square indicates the weighted mean difference (WMD),
e square is proportional to the weight that the individual study
ooled mean differences (for each outcome and overall). Meta-analysis
g 866 gestational hypertension and 408 pre-eclampsia cases.
Figure 4 (See legend on next page.)
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Figure 4 Difference in unadjusted calcium intake (mg/day) between cases (gestational hypertension, pre-eclampsia and gestational
hypertension or pre-eclampsia) and non-cases (reference) reported in case–control and cohort studies. For each study, the center of each
square indicates the weighted mean difference (WMD) and the horizontal line indicates the 95% confidence interval; the area of the square is
proportional to the weight that the individual study contributes to the overall pooled mean difference; the diamonds are pooled mean
differences (for each outcome and overall). (a) Case–control studies. Meta-analysis of 3 studies from 3 articles with data from 757 pregnant
women, including 113 gestational hypertension, 201 pre-eclampsia, and 46 gestational hypertension or pre-eclampsia cases. (b) Cohort studies.
Meta-analysis of 11 studies from 7 articles with data from 41,214 pregnant women and 908 gestational hypertension, 2,231 pre-eclampsia and 13
gestational hypertension or pre-eclampsia cases. (a) Mild pre-eclampsia; (b) severe pre-eclampsia (for definition, see Additional file 1: Table S3).
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mester, but slightly lowered the odds of developing
pre-eclampsia when assessed in the second trimester
of pregnancy (OR = 0.87, 95% CI 0.76 to 1.00).
Discussion
This study shows the sparse body of evidence from
observational studies published on the associations
between dietary factors and HDP. Meta-analyses of cohort
studies showed higher unadjusted reported energy intake
(46 kcal/day) for pr-eeclampsia cases and lower intake of
magnesium (8 mg/day) and calcium (44 mg/day) for HDPFigure 5 Adjusted association between calcium intake (highest versu
disorders of pregnancy based on case–control studies. Meta-analysis o
including 430 gestational hypertension and 387 pre-eclampsia cases. For ea
horizontal line indicates the 95% confidence interval; the area of the squar
the overall pooled odds ratios; and the diamonds are pooled odds ratios (fcases, compared with non-cases. Meta-analysis of multivar-
iable results showed an inverse association between calcium
intake and both gestational hypertension and overall HDP.
Systematic review of a few studies examining foods
and dietary patterns suggests a beneficial effect on pre-
eclampsia of a diet rich in fruit and vegetables.
To our knowledge, this is the first systematic review
and meta-analysis of observational studies examining the
association between dietary factors and gestational hyper-
tension or pre-eclampsia. Our review covered a wide range
of dietary factors, including intake of total energy, nutrients,
foods, and overall dietary patterns. Intervention studiess lowest category of intake (reference) and hypertensive
f 5 studies from 3 articles with data from 2,203 pregnant women,
ch study, the center of each square indicates the odds ratio, and the
e is proportional to the weight that the individual study contributes to
or each outcome and overall).
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pregnancy; however, evidence from observational studies of
a range of dietary factors representing habitual intake may
contribute to development of practical dietary guidelines
for pregnant women.
Our study also has several limitations. There was sub-
stantial heterogeneity beween studies examining differ-
ences in calcium intake between women with and without
HDP, which could not be further explored by subgroup
analysis because of the limited number of studies. Possible
explanations include differences in population characteristics
(ethnicity, nutrient deficiencies, economic development,
lifestyle), HDP severity, or dietary assessment methods
and timing (prior to or after diagnosis). Moreover, causal
relationships cannot be inferred from observational stud-
ies. Randomized controlled intervention trials are more
likely to minimize confounding; however, it is practically
impossible to conduct long-term controlled trials examin-
ing intake of a range of nutrients and foods or overall diets
as the exposure.
The quality of the present review is determined by the
validity of the individual studies included. Firstly, diet
was assessed using a validated FFQ in 16 of 38 studies;
however, questionnaires were not validated for use in
pregnant women in most studies. The presence of random
and systematic measurement errors in self-reported
dietary intake could attenuate the associations found,
and reduce the statistical power to detect an association.
In addition, timing of dietary assessment was not prior
to, but at or after diagnosis in case–control studies
[21,23,25,27,28,36,52-60] and two retrospective cohort
studies [35,49], which may have caused recall bias.
Additionally, dietary assessment methods differed between
studies (FFQs, dietary interviews, recalls, or records). A
dietary recall may more accurately assess actual nutrient
intake compared with an FFQ; however, possible hetero-
geneity in pooled results due to different dietary assessment
methods used could not be formally tested because of the
limited number of studies. Secondly, even though results
from unadjusted meta-analysis were generally consistent
with study results adjusted for confounding factors, studies
may have failed to control for key confounding factors.
Most studies adjusted for maternal age, parity, BMI,
smoking, socioeconomic status, and total energy intake,
and some adjusted for ethnicity and other dietary factors,
but very few adjusted for factors such as HDP in previous
pregnancy, or multiple pregnancy, gestational age, and
physical activity, which are important determinants of
HDP [3]. Furthermore, HDP are heterogeneous, and there
may be etiological differences according to severity and
timing of onset between disorders; however, few studies
reported results for these subtypes separately. Four studies
examining subtypes suggested a more pronounced risk for
severe compared with mild pre-eclampsia for lower intakeof calcium [35], vitamin C [26], and probiotics [20], and
higher consumption of tea [36]. Clausen et al. found a
significant trend towards increasing intake of energy and
sucrose across categories without pre-eclampsia, late-onset
pre-eclampsia, and early-onset pre-eclampsia [40]. The
magnitude of associations between dietary factors and
HDP might therefore not be generalizable to all subtypes
of HDP. In meta-analysis of cohort studies on difference
in calcium intake between HDP cases and non-cases, only
the study by Geraldo Lopes Ramos et al. reported on mild
and severe pre-eclampsia separately, showing a stronger
and statistically significant association of lower calcium
intake with severe pre-eclampsia compared with mild
pre-eclampsia [35]. Exclusion of the result on severe
pre-eclampsia from meta-analysis reduced the signifi-
cant between-study heterogeneity for pre-eclampsia and
HDP, as well as the statistically significant overall results
of lower calcium intake for HDP cases compared with
non-cases. Even though not all results were statistically
significant, the mostly consistent direction of lower
magnesium and calcium intake for HDP cases compared
with non-cases may indicate overlapping pathophysio-
logical mechanisms for dietary factors influencing gesta-
tional hypertension and pre-eclampsia, but this requires
further research.
Several mechanisms could explain the associations
found between dietary factors and HDP. The higher en-
ergy intake for women with HDP compared with women
without HDP may reflect an imbalance between energy
intake and expenditure, which could lead to overweight/
obesity, a potential risk factor for HDP.
The lower reported magnesium intake for HDP cases
compared with non-cases is in line with lower serum
magnesium levels found in women with pre-eclampsia
in some studies [10]. Magnesium may lower blood pres-
sure by changing nitric oxide synthesis [61]. In addition,
it has been suggested that lower magnesium intake may
reduce the prostacyclin:thromboxane ratio, and thereby
influence HDP [62].
We also observed lower reported calcium intake for
women with HDP compared with women without HDP.
Although this was not statistically significant after ad-
justment for confounding factors, studies consistently
showed decreased odds for pre-eclampsia with higher
calcium intake. It has been hypothesized that calcium in-
fluences HDP by reducing parathyroid hormone concen-
tration, leading to lower intracellular free calcium levels,
which results in smooth muscle contractility and vaso-
constriction [63]. Calcium has also been shown to affect
uteroplacental and fetoplacental blood flow by reducing
resistance in the uterine and umbilical arteries [64].
Studies in this review examining foods and dietary
patterns suggested a beneficial effect on pre-eclampsia
of a diet high in fruit and/or vegetables. Inflammation and
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ment of HDP, and lower concentrations of inflammatory
markers have been found to be associated with consump-
tion of a diet rich in fruit and vegetables [65,66]. Fruit and
vegetables are low in fat and calories, and are important
sources of nutrients related to hypertension in non-
pregnant populations including dietary fiber, calcium,
magnesium, potassium, and vitamins C [67].
Apart from intake of total energy, magnesium, calcium,
and fruit and vegetables, consumption of other nutrients
and foods were not associated with HDP. This may be due
to the studies including low-risk populations in which nu-
trient deficiencies are rare and women regularly take multi-
vitamin supplements [68], or due to lack of heterogeneity
of intake in most well-nourished populations, reducing the
ability to detect an association with HDP [42]. Further stud-
ies in different populations are needed to examine a range
of nutrients and foods in relation to HDP.
Reported differences in total energy, calcium, and magne-
sium intake between gestational hypertension or pre-
eclampsia cases and non-cases were small, suggesting that
small changes in intake of these nutrients would suppress
any differences. Reducing total energy intake and increasing
intakes of magnesium and calcium are in line with national
dietary guidelines [69] promoting a healthy weight and
consuming more fruits, vegetables, and fat-free and
low-fat dairy products.
In line with our findings, two narrative reviews both
concluded that evidence on the role of diet and HDP is
very limited, with no compelling evidence from interven-
tion or observational studies for an association between
maternal nutrient intake or nutrient supplementation
and pre-eclampsia risk, with the exception of calcium
supplementation in high-risk populations and in women
with calcium deficiency [9,10]. In the majority of studies
included in meta-analysis of WMD of calcium intake,
the reported intake was in line with the recommended
intake (>1000 mg/day [70]), with the exception of three
studies [22,35,45]. These studies showed the largest dif-
ference in calcium intake between HDP cases and non-
cases, even though not all were statistically significant.
Only the studies by Ortega et al. [45] and Geraldo Lopes
Ramos et al. [35] showed statistically significantly lower
calcium intake for cases compared with non-cases. Adher-
ence to the recommended calcium intake may therefore
have contributed to between-study heterogeneity even
though this could not be formally tested. This finding is in
line with results from randomized controlled trials showing
reduced pre-eclampsia risk with calcium supplementation
only in populations with low calcium intake. Meta-analysis
of adjusted estimates, however, showed borderline signifi-
cant findings of a reduced HDP risk with higher calcium in-
take (OR = 0.76, 95% CI 0.57 to 1.01) in study populations
with reported calcium intake >1000 mg/day [21,25,27].In addition to calcium, results from this systematic re-
view and meta-analysis suggest a role for total energy
and magnesium intake in the development of HDP, as
well as a beneficial effect on pre-eclampsia of a diet rich
in fruit and vegetables. Consistent with results from ran-
domized controlled trials on nutrient supplementation, our
results did not show associations between pre-eclampsia
and reported intakes of vitamin D, C, and E, and n-3
polyunsaturated fatty acids [11-13]. A recent meta-analysis
of dietary intervention studies showed a significant ef-
fect of dietary counseling on maternal blood pressure
(systolic blood pressure: standardized mean difference −0.26,
95% CI −0.45 to −0.07; I2 = 0%, P = <0.001, three stud-
ies; and diastolic blood pressure: standardized mean
difference −0.57, 95% CI −0.75 to −0.38; I2 = 0%, P = <0.001,
three studies), but not HDP outcomes [71].
Conclusions
Results from this systematic review and meta-analysis indi-
cate that current evidence from observational studies on
the association between dietary factors and HDP is limited.
The short-term and long-term adverse health outcomes for
both mother and offspring associated with HDP highlight
the importance of identification of preventive strategies.
Based on the cohort studies included in this review, mater-
nal dietary intake of total energy was higher for pre-
eclampsia cases compared with non-cases, although this
was not statistically significant. In line with existing guide-
lines, pregnant women should be advised to avoid exces-
sive energy intake and excessive weight gain during their
pregnancy. Furthermore, data suggest that higher calcium
and magnesium intake and a diet rich in fruit and vegeta-
bles may be beneficial for HDP. Adequate calcium and
magnesium intake may be achieved by increasing intake
of low-fat dairy and fruit and vegetables. There is a
need for well-powered prospective cohort studies and
intervention trials in a range of populations assessing
nutrition prior to and during pregnancy, examining as-
sociations with the different subtypes of HDP.
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